Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Guided Posters

Adrenal clinical

ea0056gp22 | Adrenal clinical | ECE2018

Hypoadrenalism in advanced HIV: a pilot study

Ross Ian , Millar Robert P , Mofokeng Thabiso RP , Mahomed Fazleh , Grossman Ashley , Dave Joel , Levitt Naomi , Pillay Tahir , Erasmus Rajiv , Raubenheimer Peter , Johannsson Gudmundur

Background: Addison’s disease is probably under-diagnosed in South Africa, given that the prevalence is considerably lower than reported in Western countries (Chabre O 2017); this is important as patients may be dying from a highly treatable condition. In addition, large populations of HIV and tuberculosis infected patients in South Africa may have some symptoms erroneously attributed to these conditions, rather than Addison’s disease. We determined the prevalence an...

ea0056gp23 | Adrenal clinical | ECE2018

Nicotinamide Nucleotide Transhydrogenase as a novel treatment target in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela , Doig Craig , Walsh Mark , Meimaridou Eirini , Jenkinson Carl , Rodriguez-Blanco Giovanny , Ronchi Cristina , Jaffri Alisha , Metherell Louise , Hebenstreit Daniel , Dunn Warwick , Arlt Wiebke , Foster Paul

Adrenocortical Carcinoma (ACC) is an aggressive malignancy with poor response to chemotherapy. Here we evaluated a potential new treatment target for ACC, focusing on the mitochondrial NADPH generator Nicotinamide Nucleotide Transhydrogenase (NNT). NNT has a central role within mitochondrial antioxidant pathways, protecting cells from oxidative stress. Inactivating human NNT mutations result in congenital adrenal insufficiency. We hypothesized NNT silencing in ACC cells will i...

ea0056gp24 | Adrenal clinical | ECE2018

Germline CYP2W1*6 polymorphism is a new predictive marker of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicenter European study

Altieri Barbara , Herterich Sabine , Volante Marco , Sbiera Silviu , De Francia Silvia , Casa Silvia Della , Pontecorvi Alfredo , Quinkler Markus , Kienitz Tina , Mannelli Massimo , Canu Letizia , Chortis Vasileios , Kaltsas Gregory , Kroiss Matthias , Terzolo Massimo , Fassnacht Martin , Ronchi Cristina L

The cytochrome P450 2W1 (CYP2W1) is an orphan enzyme able to activate anticancer pro-drugs and to metabolise endogenous substances as fatty acids and lysophospholipids. Aim of the study was to evaluate the frequency of CYP2W1 polymorphisms in patients with adrenocortical carcinoma (ACC) and correlate it with the sensitivity to mitotane, which represents the only approved drug for the treatment of advanced ACC.Methods: A multicenter retrospective study in...

ea0056gp25 | Adrenal clinical | ECE2018

Metabolic fingerprints after Cushing syndrome cure

Garcia-Eguren Guillermo , Vizan Pedro , Gonzalez Mar , Blanco Enrique , Rojo Marina , Mora Mireia , Giro Oriol , Halperin Irene , Di Croce Luciano , Hanzu Felicia A

Introduction: Active hypercortisolism of Cushing syndrome (CS) determines major changes in the plasticity and function of metabolic key target tissues as the adipose tissue (AT). Persistence of target tissue altered metabolic memory after the cure/remission of Cushing syndrome is still at debate as clinical observational studies are limited due to confounder factors both in endogenous as exogenous CS. We postulate that after remission of hypercortisolism, adipose tissue (AT) p...

ea0056gp26 | Adrenal clinical | ECE2018

Segmental adrenal venous sampling may give a key to solution about the debate of cosyntropin stimulation or not

Satoh Fumitoshi , Tezuka Yuta , Morimoto Ryo , Omata Kei , Ono Yoshikiyo , Igarashi Yasuhiro , Kudo Masataka , Takase Kei , Ito Sadayoshi

Background: Adrenal venous sampling (AVS) is critical to differentiate unilateral primary aldosteronism (PA) subtype. However, there are large discrepancies between institutions in the diagnostic criteria of AVS. Especially, the most major debate is in whether cosyntropin stimulation should be used for localization diagnosis or not. Segmental AVS (S-AVS) is a refinement of central AVS (C-AVS) in which samples are taken from the tributaries of the central adrenal veins allowing...

ea0056gp27 | Adrenal clinical | ECE2018

The short synacthen test can be used to predict recovery of hypothalamo-pituitary-adrenal axis function and guide clinical practice

Pofi Riccardo , Feliciano Chona , Sbardella Emilia , Argese Nicola , Woods Conor P , Grossman Ashley B , Jafar-Mohammadi Bahram , Gleeson Helena , Lenzi Andrea , Isidori Andrea M , Tomlinson Jeremy W

The 250 mg short synacthen test (SST) is the most commonly used tool to assess the integrity of hypothalamic-pituitary-adrenal (HPA) axis. There are many instances when compromise to HPA-axis function is potentially reversible (including the use of suppressive dose of prescribed glucocorticoids), but currently there are no data to guide clinicians as to the frequency of repeat testing or to the likelihood of HPA-axis recovery. We performed an observational, retrospective, anal...

ea0056gp28 | Adrenal clinical | ECE2018

Immunohistochemical staining for histopathological subclassification of primary aldosteronism: nationwide 10-year results from Iceland

Gunnarsdottir Hrafnhildur , Agnarsson Bjarni A , Jonasdottir Sigurros , Birgisson Guojon , Sigurjonsdottir Helga Agusta

Introduction: Primary aldosteronism (PA) is an important cause of hypertension. Adrenal hyperplasia (AH) and aldosterone-producing adrenocortical adenoma (APA) are considered the most frequent causes of PA. Histopathological analysis of unilateral PA has been difficult since no clear morphological criteria existed for defining aldosterone-producing cells. Recently, the distribution of adrenal cells forming aldosterone and cortisol has been studied by using specific monoclonal ...

ea0056gp29 | Adrenal clinical | ECE2018

Salivary cortisol and cortisone in Cushing diagnosis – reference ranges and clinical cut off limits

Backlund Nils , Brattsand Goran , Israelsson Marlen , Ragnarsson Oskar , Burman Pia , Engstrom Britt Eden , Hoybye Charlotte , Berinder Katarina , Wahlberg Jeanette , Dahlqvist Per

Introduction: Cushing’s syndrome is rare, but assessment of patients with clinical suspicion of Cushing’s and/or adrenal incidentaloma is frequently required. Thus, there is a need for biochemical screening methods that with high sensitivity and specificity identifies or rule out hypercortisolism. Analysis of late night salivary cortisol allows an easy sampling procedure performed at home and is independent of variations in plasma CBG levels. Analysis by liquid chrom...

ea0056gp30 | Adrenal clinical | ECE2018

The urinary cortisol metabolome in patients with adrenal insufficiency: dual-release hydrocortisone is less deleterious than conventional hydrocortisone therapy

Espiard Stephanie , McQueen Johanna , Sherlock Mark , Ragnarsson Oskar , Bergthorsdottir Ragnhildur , Burman Pia , Dahlqvist Per , Ekman Bertil , Engstrom Britt Eden , Nilsson Anna G , Skrtic Stanko , Wahlberg Jeanette , Stewart Paul M , Johannsson Gudmundur

Introduction: Oral once-daily dual-release hydrocortisone (DR-HC) therapy provides a more physiological cortisol profile than conventional thrice-daily (TID) replacement therapy and has demonstrated improved metabolic profile among patients with adrenal insufficiency (AI). The mechanisms by which this metabolic improvement occurs may be due to less total exposure, changed cortisol time exposure profile, but also modified metabolism of cortisol.Objective:...

ea0056gp31 | Adrenal clinical | ECE2018

Circular RNA circ0066659 functions as a competitive endogenous RNA by sponging miR-506-3p in adrenocortical carcinoma

Xu Yunze , Huang Yiran

Introduction and objectives: Circular RNAs (circRNAs) represent a class of endogenous noncoding RNAs that have recently been recognized as important regulators of gene expression and pathological networks. However, investigations on adrenocortical carcinoma (ACC) initiation and progression mechanisms only focus on key encoding genes, but neglect shedding an insight into circRNAs.Materials and methods: We investigated the expression profile of circRNAs in...